The market is segmented based on , By Product Type (Epoetin-Alfa, Epoetin-Beta, Epoetin-Omega, Epoetin-Delta, Darbepoetin-Alfa), Disease Cured (Oncology Diseases, Kidney Disorders, Anemia, Neural Disease, Wound Healing, Antiretroviral Treatment (ART), Cancer Chemotherapy) – Industry Trends and Forecast to 2029.
.
The Global Erythropoietin Stimulating Agents Market size was valued at USD 14.46 USD Billion in 2021.
The Global Erythropoietin Stimulating Agents Market is projected to grow at a CAGR of 10.25% during the forecast period of 2022 to 2029.
The major players operating in the market include Amgen Inc , Biocon , F. Hoffmann-La Roche Ltd , Pfizer Inc , Johnson & Johnson Private Limited , Teva Pharmaceutical Industries Ltd , Thermo Fisher Scientific Inc. , Hospira Inc. , 3SBio Group , Celltrion Inc. , Intas Pharmaceuticals Ltd. .
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America..
Corporate Email ID Only (Avoid Using Generic mail ID such as Gmail)
Consent Preferences
We use cookies to improve your experience We use cookies to deliver the best possible experience on our website. To learn more, visit our Privacy Policy. By continuing to use this site, or closing this box, you consent to our use of cookies. Cookie Notice.
The data presented is for visualization purposes only and may not reflect actual results.